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Background: A new accelerated dobutamine-atropine stress echocardiography (DSE) protocol has already demonstrated a diagnostic accuracy 
and a safety profile similar to the classic protocol. This study sought to define the prognostic power of this new protocol in predicting the long term 
outcome of patients (pts) with known or suspected coronary artery disease and to analyze the predictors of major adverse cardiac events (MACE).
Methods: In this multicenter study, DSE studies were performed using an incremental accelerated dobutamine infusion protocol from 20 to 40 
μg/kg/min in 3-minute stages (total: 6 minutes) and followed by atropine. Pts were eligible when referred for DSE with diagnostic or prognostic 
intentions. Outcome data were collected from pts´ interviews and hospital chart reviews. MACE included cardiac death, non-fatal MI and the need 
for coronary revascularization.
Results: A total of 962 pts were included (mean age 64±11 years, 61% male). Mean follow-up was 1353±491 days. Complete follow-up was 
achieved in 942 pts (97.9%). Regarding MACE, 116 events were reported (12.5%): 21 cardiac deaths (2.3%), 27 non-fatal MI (2.9%) and 81 
revasculrizations (>3 months after DSE, 8.6%). Independent predictors of MACE were: hypertension(OR: 1.96; 95% CI 1.14-3.38; p=0.01), previous 
revascularization (OR: 1.79; 95% CI 1.03-3.11; p=0.04), stable (OR: 2.41; 95% CI 1.32-4.41; p=0.006) and unstable angina (OR: 2.34; 95% CI 
1.15-4.74; p=0.02) as reasons for DSE testing and DSE positivity (OR: 2.19; 95% CI 1.29-3.70; p=0.005). There was a trend towards a protective 
effect of previous treatment with β-blockers (OR: 0.60; 95% CI 0.36-1.02; p=0.06).
Conclusions: The accelerated DSE protocol has a similar prognostic power to the classic protocol. Echocardiographic positivity with this protocol 
is an independent predictor of MACE at long term follow-up.
